Bridgewealth Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$570K Buy
2,332
+11
+0.5% +$2.56K 0.12% 74
2025
Q4
$480K Buy
2,321
+107
+5% +$21.2K 0.11% 79
2025
Q3
$410K Buy
2,214
+8
+0.4% +$1.37K 0.1% 77
2025
Q2
$337K Buy
+2,206
New +$339K 0.09% 82
2025
Q1
Sell
-2,466
Closed -$388K 76
2024
Q4
$388K Buy
2,466
+874
+55% +$135K 0.11% 68
2024
Q3
$258K Buy
+1,592
New +$254K 0.09% 68

Other funds holding JNJ

Bridgewealth Advisory Group's JNJ Position: Q1 2026 in Review

Bridgewealth Advisory Group increased its Johnson & Johnson (JNJ) stake by 0.47% in Q1 2026, buying an estimated $2.56K and bringing the position to 2,332 shares worth $570K. The position accounts for 0.12% of the portfolio, ranked #74.

Bridgewealth Advisory Group first reported a position in JNJ in Q3 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bridgewealth Advisory Group held 2,332 shares of Johnson & Johnson worth $570K as of Q1 2026.
  • Bridgewealth Advisory Group bought 11 Johnson & Johnson shares in Q1 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.12% of Bridgewealth Advisory Group's portfolio in Q1 2026, its #74 holding.
  • Bridgewealth Advisory Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bridgewealth Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.